Advertisement
Advertisement

ABVC

ABVC logo

ABVC BioPharma, Inc. Common Stock

2.71
USD
+0.31
+13.12%
Aug 01, 15:55 UTC -4
Closed
exchange

After-Market

2.79

+0.07
+2.58%

ABVC BioPharma, Inc. Common Stock Profile

About

ABVC BioPharma Inc. is a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system, ophthalmology and oncology/hematology indications. ABVC BioPharma Inc. is based in SILICON VALLEY, CA.

Info & Links

CEO

Uttam Patil

Headquarters

44370 Old Warm Springs Blvd
Fremont, CA 94538, UNITED STATES

Sector

Medical

Auditor

Simon & Edward, LLP

Share holders

656

Employees

19

ABVC BioPharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

47.29M

Enterprise Value

48.17M

Enterprise Value/EBITDA(ttm)

-20.52

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

96.09

Price to Book(mrq)

5.71

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

49.94%

Operating Margin(ttm)

-963.46%

Profit Margin(ttm)

-228.10%

Return on Equity(ttm)

-29.62%

Return on Invested Capital(ttm)

-157.50%

Return on Assets(ttm)

-14.08%

Income Statement

Revenue(ttm)

508.40K

Revenue Per Share(ttm)

0.03

Gross Profit(ttm)

508.00K

EBITDA(ttm)3

-2.35M

Net Income Available to Common(ttm)

-2.91M

Diluted EPS(ttm)

-0.13

Share Statistics

Beta (5Y Monthly)

0.37

52-Week Change

248.43%

S&P 500 52-Week Change

16.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

16.77M

Dividend Yield

0.00%

Float4

14.08M

% Held by Insiders

17.10%

% Held by Institutions

11.38%

Balance Sheet

Total Cash(mrq)

824.60K

Total Cash Per Share(mrq)

0.05

Total Debt(mrq)

1.64M

Total Debt/Equity(mrq)

20.57%

Current Ratio(mrq)

0.22%

Quick Ratio(mrq)

0.22%

Book Value Per Share(mrq)

0.54

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.04

Free Cash Flow(ytd)

-539.80K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement